14-Dec-2007 FMC and Pronova announce agreement

FMC Corporation (NYSE: FMC) and Pronova BioPharma ASA (OSE: PRON) today announced the companies have entered into a worldwide license and development agreement to develop products using a novel capsule technology developed by FMC.

Click here to view a press release
Terms & Conditions Privacy Statement
Login